指南与共识鼻科

原发性弥漫型2型优势慢性鼻窦炎手术治疗专家共识

Expert Consensus on Surgical Management of Primary Diffuse Type 2-Dominant Chronic Rhinosinusitis.
指南 / 共识 · Int Forum Allergy Rhinol · 2025-02-10

该共识由欧洲、英国、澳大利亚、南非、北美和南美专家组成共识组,采用改良德尔菲法,经文献回顾形成67条陈述并在第二轮增加1条,最终在2023年10月希腊圣托里尼共识会议上讨论。68条陈述中45条达成共识,其中34条中位评分为7分(强烈同意),11条为6分(同意)。推荐涵盖手术适应证、时机、范围及术中管理,强调完整鼻窦手术及在考虑单克隆抗体治疗前先行完整鼻窦手术(除非禁忌)。

要点

  • 68条陈述中45条达成共识,34条中位评分7分(强烈同意),11条6分(同意)。
  • 完整鼻窦手术包括切除筛窦骨隔形成新鼻窦腔,并按需开放额窦和蝶窦。
  • 共识认为在考虑单克隆抗体治疗前应先行完整鼻窦手术,除非有禁忌。

核心结论

  • 45条共识陈述基于当前证据和专家意见,为临床医生手术治疗原发性弥漫型2型优势慢性鼻窦炎提供指导。

研究设计与样本

  • 共识组由来自欧洲、英国、澳大利亚、南非、北美和南美的专家组成,采用改良德尔菲法。
  • 经文献回顾形成67条陈述,第二轮增加1条,共68条;最终推荐在2023年10月希腊圣托里尼共识会议上讨论。

主要发现

  • 68条陈述中45条达成共识,其中34条中位评分为7分(强烈同意),11条中位评分为6分(同意)。
  • 最终推荐涵盖原发性弥漫型2型优势慢性鼻窦炎初次和修正手术的适应证、时机、手术范围及术中管理。
  • 重点为完整鼻窦手术,即通过切除筛窦骨隔形成新鼻窦腔,并按需开放额窦和蝶窦。
  • 充分的初次和修正手术包括清除所有鼻息肉和病变黏膜,同时确保局部治疗的理想条件。
  • 共识认为在考虑单克隆抗体治疗前应先行完整鼻窦手术,除非有禁忌。

关键数值与推荐

  • 45条共识陈述涵盖适应证、时机、手术范围及术中管理。
  • 完整鼻窦手术包括切除筛窦骨隔形成新鼻窦腔,并按需开放额窦和蝶窦。
  • 充分的初次和修正手术包括清除所有鼻息肉和病变黏膜,并确保局部治疗的理想条件。
  • 在考虑单克隆抗体治疗前应先行完整鼻窦手术,除非有禁忌。

临床怎么用

  • 共识推荐完整鼻窦手术作为原发性弥漫型2型优势慢性鼻窦炎的手术方式,包括切除筛窦骨隔形成新鼻窦腔并按需开放额窦和蝶窦。
  • 共识推荐充分的初次和修正手术应清除所有鼻息肉和病变黏膜,并确保局部治疗的理想条件。
  • 共识认为在考虑单克隆抗体治疗前应先行完整鼻窦手术,除非有禁忌。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic rhinosinusitis (CRS) poses significant challenges in surgical management due to the lack of clear guidelines, particularly in type 2 CRS. This review focuses on surgical approaches for primary diffuse type 2-dominant CRS, emphasizing preoperative and intraoperative strategies. METHODS: A consensus group, comprising experts from Europe, United Kingdom, Australia, South Africa, North and South America, was assembled. Using a modified Delphi method, 67 statements were formulated following a literature review, with an additional statement added in the second iteration. Final recommendations were discussed during a consensus meeting in Santorini, Greece, in October 2023. RESULTS: Out of the 68 proposed statements, consensus was achieved on 45. Most (34) statements received a median score of 7 (strongly agree), and 11 had a median score of 6 (agree). The finalized recommendations cover the indications, timing, extent of surgery, and intraoperative management for both primary and revision surgery in primary diffuse type 2-dominant CRS. A key focus is on complete sinus surgery, which involves creating a neo-sinus cavity by removing bone partitions in the ethmoid and opening the frontal and sphenoidal sinuses as needed. Adequate primary and revision surgery includes clearing all nasal polyps and diseased mucosa while ensuring ideal conditions for topical therapy. Additionally, there was consensus on performing complete sinus surgery before considering monoclonal antibody therapies, unless contraindicated. CONCLUSION: These 45 consensus statements, derived from both current evidence and expert opinion, provide valuable guidance for clinicians in the surgical management of primary diffuse type 2-dominant CRS.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Blauwblomme M, Georgalas C, Ahmed S, et al. Expert Consensus on Surgical Management of Primary Diffuse Type 2-Dominant Chronic Rhinosinusitis. Int Forum Allergy Rhinol. 2025. PMID: 39927867. doi:10.1002/alr.23538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。